hospital at home

Chronic care

Connecting care teams with patients to provide remote care for those who have long-term conditions. This eases pressure on healthcare systems and empowers patients to improve their health.

Caring for patients with diabetes

Illustration of Huma hospital at home chronic care diabetes sample images on various devices.

Using Huma’s technology, healthcare systems are supporting each patient to manage their chronic disease and improve their quality of life and health outcomes.

Huma in partnership with Discover-NOW, health data research hub for real world evidence, and Know Diabetes are enabling remote care for people living with type 2 diabetes. Together we are utilising real world data to support high-quality research, with the ambition of transforming care pathways for patients with type 2 diabetes.

Stats arrow pointing down. 0kg

weight loss1


adherence rate1

Stats arrow pointing down. 0mmol/mol

average reduction
in HbA1c1

Caring for people with congenital heart disease

Illustration of Huma hospital at home chronic care diabetes sample images on various devices.
NHS HUMA logo.

Many patients require long-term care to monitor and manage their illness.

The Royal Brompton NHS hospital uses our 'hospital at home' technology to care for people born with complex congenital heart disease who require frequent and regular assessments.

Using our technology the clinical teams can remotely monitor patients wherever they are and engage them closely in their own health management.

Delivering a fully-remote Atrial Fibrillation trial

Illustration of Huma hospital at home chronic care diabetes sample images on various devices.
Bayer & Stanford - HUMA logo.

Huma is currently working with Bayer, Stanford Medicine and the Stanford Center for Digital Health (CDH) to validate an approach to decentralize the clinical trial experience for patient participants with atrial fibrillation. The study aims to prove the feasibility, acceptability, and best practices that can achieve high compliance, quality, and scientifically sound fully remote clinical trials.


94% of participants
recruited in 12 days2


Increased oral anticoagulation adherence from 85% to 96% in patients with low baseline adherence2



personalised care

Clinical pathways designed for your patients

Our ‘hospital at home’ technology can monitor a wide range of diseases and be configured to meet the needs of your patient population. Download our guide to find out more.3

This field is required

Success message illustration with 'thumbs up'.
One of our team members will be in touch with you shortly.
There was an error submitting your form. Please refresh and try again.


Read more about Huma


1. Data from 2021 pilot study. Full evaluation of the service is in preparation.

2. Data from 2021 single-arm, six-month study. Paper in submission.

3. Huma is committed to respecting your privacy, and we’ll only use your personal details to send you the Huma Healthcare Guide. You can review our Privacy Policy for further information.

Cookie settings